» Articles » PMID: 8075011

The Scientific Challenge of Langerhans Cell Histiocytosis

Overview
Specialty Oncology
Date 1994 Sep 1
PMID 8075011
Authors
Affiliations
Soon will be listed here.
Abstract

Langerhans cell histiocytosis is difficult to study because of its rarity. Although recent studies indicate that it may be a clonal proliferation this does not prove that it is a malignant tumour. New methods for culturing dendritic cells and their precursors provide the opportunity to resolve issues relating to clonality, underlying genetic lesions and functional abnormalities in LCH or other lesional cells. The expression of the CD1a antigen on LCH cells provides a target for therapy.

References
1.
Handman E, Ceredig R, Mitchell G . Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages. Aust J Exp Biol Med Sci. 1979; 57(1):9-29. DOI: 10.1038/icb.1979.2. View

2.
Willman C, Busque L, Griffith B, Favara B, McClain K, Duncan M . Langerhans'-cell histiocytosis (histiocytosis X)--a clonal proliferative disease. N Engl J Med. 1994; 331(3):154-60. DOI: 10.1056/NEJM199407213310303. View

3.
Allan J, Doherty P . Immune T cells can protect or induce fatal neurological disease in murine lymphocytic choriomeningitis. Cell Immunol. 1985; 90(2):401-7. DOI: 10.1016/0008-8749(85)90204-7. View

4.
Goldberg N, Bauer K, Rosen S, CARO W, Marder R, Zugerman C . Histiocytosis X. Flow cytometric DNA-content and immunohistochemical and ultrastructural analysis. Arch Dermatol. 1986; 122(4):446-50. DOI: 10.1001/archderm.122.4.446. View

5.
Baenziger J, Hengartner H, Zinkernagel R, Cole G . Induction or prevention of immunopathological disease by cloned cytotoxic T cell lines specific for lymphocytic choriomeningitis virus. Eur J Immunol. 1986; 16(4):387-93. DOI: 10.1002/eji.1830160413. View